Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FhCMB receives NIH anthrax vaccines development contract
National Institute of Allergy and Infectious Diseases is part of the National Institutes of Health (NIH). As part of the contract, Fraunhofer will receive $1.76m for the first
National Institute of Allergy and Infectious Diseases is part of the National Institutes of Health (NIH). As part of the contract, Fraunhofer will receive $1.76m for the first
Patent broadly covers RNA-based oligonucleotide therapeutics such as a RNA duplex, a microRNA mimic, a microRNA antagonist and a RNA-binding RNA steric blocker containing a UNA. The RNA
Epigenomics chief financial officer and acting chief executive officer Thomas Taapken said based on the achieved non-inferiority in CRC detection, the company believes that Epi proColon has demonstrated
The new patent entitled Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy provides protection until December 2019. Jazz Pharmaceuticals chairman and chief executive
TTC transactions operations director Brandon Fitzgerald said TTC is pleased to close the transaction for UCH, who had built a local business that served community for almost two
Vertigo occurs more in women ages 50-60 or the elderly with debilitating symptoms including dizziness, nausea, disorientation, and a spinning sensation. Vertigo, in general, is treated with prescription
Using its new office, Essex Woodlands will assist Chinese entrepreneurs to construct companies in all sectors of the Chinese healthcare industry. Shanghai office co-managing director David Yang said,
According to the agreement, Teva Israel will be responsible for regulatory registration and commercialization activities of the product in the region besides funding for local development. Galena is
The drugs are indicated for pharyngitis, nasopharynx, gastroenteropathy, nephropathy, asthma, hyperplasia of mammary glands, dermatosis, gynecological diseases, etc. Biostar chief executive officer and chairman Ronghua Wang said the
The PJ-01 development project will leverage Parabon’s Essemblix drug development platform to design macromolecules and nanoscale fabrication technology used in the production. The NSF grant program funds technology